Chorus Sleep vs Andson Biotech
Side-by-side comparison of AI visibility scores, market position, and capabilities
US YC W21 employee sleep wellness platform at $2M revenue 2024 with 13 employees; M&A offer Apr 2025; CBT-I behavioral sleep coaching and tracking competing with Headspace Health for employer-sponsored sleep wellness.
About
Chorus Sleep is a United States-based employee sleep wellness platform — backed by Y Combinator (W21) — providing employers with a mobile app and coaching program that helps employees improve their sleep quality through audio sessions, behavioral coaching, sleep tracking, and interactive content designed to address the clinical and workplace productivity costs of poor sleep. Founded in 2019 by Ali Abramovitz, MK Hurlbutt, and Warren Runk, Chorus Sleep achieved $2 million in revenue in 2024 with a 13-person team, receiving an M&A acquisition offer in April 2025 — positioning as an employee benefits platform in the growing workplace wellness market where employers invest in targeted health interventions with measurable ROI in reduced absenteeism and healthcare costs.
Mass spectrometry sample prep and data science platform delivering 100x productivity for biopharma protein analysis; $9.1M from Merck Digital Sciences Studio, NIH, and YC at $1.8M revenue.
About
Andson Biotech is an Atlanta-based healthcare technology company providing mass spectrometry solutions for biopharma and biomanufacturing — offering the DynaCHIP hardware system (a novel mass spectrometry sample preparation platform) and DynaMARK data science module that together deliver up to 100x productivity improvements in protein and biomolecule analysis workflows compared to conventional mass spectrometry setups. Backed by Y Combinator, Merck Digital Sciences Studio, and NIH with $9.1 million raised, Andson achieved $1.8 million in revenue as of December 2024.
AI Visibility Head-to-Head
Capabilities & Ecosystem
Capabilities
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.